V86-15931-03186
2 vaccinations
2 coded responses
9 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 126 / NY
- Registered
- 2021-03-25
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-04
Dose 1 — Pfizer-BioNTech
-
2021-03-25
Registered in v-safe
-
2021-03-25
Dose 2 — Pfizer-BioNTech
- 2021-03-25
- 2021-03-27
- 2021-03-28
-
2021-03-29
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-03-30
- 2021-03-31
-
2021-04-01
Survey response — day 7, dose 2MedDRA: Dyspnoea — Feeling: Fair · Fatigue or tirednessFree text: Shortness of breathMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-24
Survey response — day 28, dose 2MedDRA: Dyspnoea, Tachycardia — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Shortness of breath, tachycardiaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-09-25
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-04 | Pfizer-BioNTech | |
| 2 | 2021-03-25 | Pfizer-BioNTech |
Free text
Release 6 — day 7, dose 2
Systemic reaction (other): Shortness of breath
Release 7 — day 28, dose 2
Symptoms: Shortness of breath, tachycardia
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Dyspnoea | ✓ | ✓ | ✓ |
| SD | Tachycardia | ✓ | ✓ | ✓ |
| SRO | Dyspnoea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release